MS activity alters with seasons, US researchers say

Brain scan of MS patient The researchers compared MS brain lesions with weather patterns

Related Stories

The severity of multiple sclerosis (MS) may change with the seasons, say US researchers.

Brain scans of patients compared with weather patterns at the time showed higher levels of disease activity in the spring and summer.

The US researchers said the findings had implications for testing new medicines, which may show up different results depending on the time of year.

It is not clear why warmer weather would have this effect.

Other studies have shown that vitamin D from exposure to sunlight may have a protective effect against MS - a long-term inflammatory condition of the central nervous system.

For the study, researchers compared MRI brain scans of 44 people taken from 1991 to 1993 to daily temperature, solar radiation and precipitation measurements over the same time.

The adults in the study, who had untreated MS, had eight weekly scans followed by eight scans every fortnight then six monthly check-ups - an average of 22 scans per person.

After one year, 310 new brain lesions were found in 31 people, they reported in Neurology.

The lesions were up to three times more likely to appear in the warmer spring and summer months.

Start Quote

Future studies should further explore how and why environmental factors play a role in MS”

End Quote Dr Anne Cross

Further analysis also showed that there was a link between both new disease activity and intensity of disease activity and the warmer months.

Trial results

Study leader Dr Dominik Meier, from Brigham and Women's Hospital in Boston, said: "Not only were more lesions found during the spring and summer seasons, our study also found that warmer temperatures and solar radiation were linked to disease activity."

He pointed out that clinical trials often use MRI (magnetic resonance imaging) to assess the effectiveness of a drug and studies commonly last between six and 12 months, which may have implications for how effective a new medication seems.

In an accompanying editorial Dr Anne Cross, from Washington University School of Medicine, added: "This is an important study because it analyses records from the early 1990s, before medications for relapsing MS were approved, so medicines likely could not affect the outcome.

"Future studies should further explore how and why environmental factors play a role in MS."

Dr Susan Kohlhaas, research communications officer at the MS Society, said more research was needed.

But added: "This small study is intriguing and, if validated in larger studies, has the potential to influence the way clinical trials are designed."

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Health stories


Features & Analysis

  • Dana Lone HillDana Lone Hill

    The Native American names that break Facebook rules

  • Painting from Rothschild collectionDark arts Watch

    The 50-year fight to recover paintings looted by the Nazis

  • Mukesh SinghNo remorse

    Delhi bus rapist says victim shouldn't have fought back

  • Signposts showing the US and UK flagsAn ocean apart

    How British misunderstanding of the US is growing

Elsewhere on the BBC

  • StudentsBull market

    Employers are snapping up students with this desirable degree


  • Former al-Qaeda double agent Aimen DeanHARDtalk Watch

    Islamic State is about revenge says former al-Qaeda member turned spy Aimen Dean

Try our new site and tell us what you think. Learn more
Take me there

Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.